weight loss drugs other than glp 1 Half of GLP-1 users ditch their injections — and some are turning to weight-loss methods instead How GLP-1 medications are transforming

Once available, retatrutide will likely be administered as a weekly injection under the skin (subcutaneous)

Diabetes Atlas 10th edn (International Diabetes Federation, 2021)

Firstly because of the abundance of GLP-1 receptors in the brain, and secondly because the brain and the immune system communicate with all organs in the body (Lunenfeld-Tanenbaum Research Institute)

On the other hand, it is still not entirely clear whether the hepatic effects of GLP-1 are direct or indirect, as recent studies have not clearly demonstrated the presence of GLP-1 receptors in human hepatocytes

A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study was done to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of orforglipron

At 48 weeks, for example, retatrutide had reduced levels of triglycerides by up to 40.6% , and levels of a protein called apoC-III involved in glucose metabolism and inflammation by 38%